Y Kurusu1, J Yamashita, M Ogawa. 1. Department of Surgery II, Kumamoto University School of Medicine, Japan.
Abstract
OBJECTIVE: We tested whether circulating tumor cells can be detected in the peripheral blood of patients with resectable non-small-cell lung cancer (NSCLC) by reverse transcriptase-polymerase chain reaction (RT-PCR) of carcinoembryonic antigen (CEA) mRNA. METHODS: We assayed for CEA mRNA by RT-PCR in the peripheral blood, taken at the time of diagnosis before surgical intervention and again 2 to 3 weeks postoperatively, from 103 patients with NSCLC who underwent curative lobectomy. Blood samples taken from 15 patients with interstitial pulmonary fibrosis who underwent an open-lung biopsy and from 32 healthy subjects served as controls. RESULTS: No control samples were positive for CEA by RT-PCR. Sixty-two (60%) of the preoperative blood samples from the 103 patients with NSCLC were positive. Of these 62 samples, 27 (44%) remained positive even after surgical intervention, whereas the remaining 35 samples (56%) became negative. The incidence of positive CEA mRNA correlated highly with pathologic TNM stage of disease in both the preoperative and postoperative blood samples. CONCLUSIONS: Many patients with resectable NSCLC have detectable levels of circulating cells expressing carcinoembryonic antigen even after surgical intervention. Such patients may have a higher rate of relapse.
OBJECTIVE: We tested whether circulating tumor cells can be detected in the peripheral blood of patients with resectable non-small-cell lung cancer (NSCLC) by reverse transcriptase-polymerase chain reaction (RT-PCR) of carcinoembryonic antigen (CEA) mRNA. METHODS: We assayed for CEA mRNA by RT-PCR in the peripheral blood, taken at the time of diagnosis before surgical intervention and again 2 to 3 weeks postoperatively, from 103 patients with NSCLC who underwent curative lobectomy. Blood samples taken from 15 patients with interstitial pulmonary fibrosis who underwent an open-lung biopsy and from 32 healthy subjects served as controls. RESULTS: No control samples were positive for CEA by RT-PCR. Sixty-two (60%) of the preoperative blood samples from the 103 patients with NSCLC were positive. Of these 62 samples, 27 (44%) remained positive even after surgical intervention, whereas the remaining 35 samples (56%) became negative. The incidence of positive CEA mRNA correlated highly with pathologic TNM stage of disease in both the preoperative and postoperative blood samples. CONCLUSIONS: Many patients with resectable NSCLC have detectable levels of circulating cells expressing carcinoembryonic antigen even after surgical intervention. Such patients may have a higher rate of relapse.
Authors: Linda W Martin; Jonathan D'Cunha; Xiaofei Wang; Debra Herzan; Lin Gu; Naif Abraham; Todd L Demmy; Frank C Detterbeck; Shawn S Groth; David H Harpole; Mark J Krasna; Kemp Kernstine; Leslie J Kohman; G Alexander Patterson; David J Sugarbaker; Robin T Vollmer; Michael A Maddaus; Robert A Kratzke Journal: J Clin Oncol Date: 2016-02-29 Impact factor: 44.544
Authors: Jay M Lee; Mi-Heon Lee; Edward Garon; Jonathan W Goldman; Ramin Salehi-Rad; Felicita E Baratelli; Dörthe Schaue; Gerald Wang; Fran Rosen; Jane Yanagawa; Tonya C Walser; Ying Lin; Stacy J Park; Sharon Adams; Francesco M Marincola; Paul C Tumeh; Fereidoun Abtin; Robert Suh; Karen L Reckamp; Gina Lee; William D Wallace; Sarah Lee; Gang Zeng; David A Elashoff; Sherven Sharma; Steven M Dubinett Journal: Clin Cancer Res Date: 2017-05-03 Impact factor: 12.531
Authors: Michael Mitas; Loretta Hoover; Gerard Silvestri; Carolyn Reed; Mark Green; Andrew T Turrisi; Carol Sherman; Kaidi Mikhitarian; David J Cole; Mark I Block; William E Gillanders Journal: J Mol Diagn Date: 2003-11 Impact factor: 5.568
Authors: André A Adams; Paul I Okagbare; Juan Feng; Matuesz L Hupert; Don Patterson; Jost Göttert; Robin L McCarley; Dimitris Nikitopoulos; Michael C Murphy; Steven A Soper Journal: J Am Chem Soc Date: 2008-06-17 Impact factor: 15.419